HANDBOOK OF GENERAL MEDICINE VOL 1:@0.076190:0.972666:0.349932:0.972666:0.349932:0.958637:0.076190:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
66:@0.083944:0.033217:0.104640:0.033217:0.104640:0.013052:0.083944:0.013052:0.010348:0.010348
TREATMENT AppROACHEs:@0.397030:0.032906:0.624375:0.032906:0.624375:0.013617:0.397030:0.013617:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
• :@0.076190:0.084931:0.089540:0.084931:0.089540:0.069149:0.076190:0.069149:0.009162:0.004188
theophylline:@0.096344:0.084931:0.188570:0.084931:0.188570:0.068433:0.096344:0.068433:0.006350:0.009071:0.009676:0.009676:0.009979:0.009071:0.008769:0.003629:0.003629:0.003629:0.009071:0.009676
 :@0.076190:0.099074:0.080378:0.099074:0.080378:0.083292:0.076190:0.083292:0.004188
In the majority of cases, ß-2 agonists are the preferred :@0.096344:0.099074:0.485130:0.099074:0.485130:0.083292:0.096344:0.083292:0.003417:0.009223:0.003372:0.005125:0.009223:0.009827:0.003356:0.014182:0.010326:0.003069:0.009903:0.004551:0.003024:0.005125:0.008104:0.003372:0.009903:0.004747:0.003356:0.009782:0.010326:0.005866:0.009827:0.005866:0.004188:0.003372:0.008376:0.005020:0.008376:0.003372:0.010326:0.010175:0.009903:0.009223:0.003024:0.005866:0.005125:0.005866:0.003372:0.010326:0.004551:0.009827:0.003356:0.005125:0.009223:0.009827:0.003356:0.010311:0.004551:0.009827:0.004747:0.009827:0.004551:0.004551:0.009827:0.010357:0.004188
bronchodilator because of fewer side effects and a :@0.096344:0.113218:0.485130:0.113218:0.485130:0.097435:0.096344:0.097435:0.010311:0.004551:0.009903:0.009223:0.009782:0.009223:0.009903:0.010357:0.003024:0.003024:0.010326:0.005125:0.009903:0.004551:0.004974:0.010311:0.009827:0.009782:0.010326:0.009192:0.005866:0.009827:0.004989:0.009903:0.004747:0.004974:0.004747:0.009827:0.012564:0.009827:0.004551:0.004974:0.005866:0.003024:0.010357:0.009827:0.004989:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.004974:0.010326:0.009223:0.010357:0.004989:0.010326:0.004188
comparable effect. In adults, their role may be lim-:@0.096344:0.127361:0.480942:0.127361:0.480942:0.111578:0.096344:0.111578:0.009782:0.009903:0.014182:0.010311:0.010326:0.004551:0.010326:0.010311:0.003024:0.009827:0.005760:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.004188:0.005745:0.003417:0.009223:0.005760:0.010326:0.010357:0.009192:0.003024:0.005125:0.005866:0.004188:0.005760:0.005125:0.009223:0.009827:0.003024:0.004551:0.005745:0.004551:0.009903:0.003024:0.009827:0.005745:0.014182:0.010326:0.008104:0.005760:0.010311:0.009827:0.005760:0.003024:0.003024:0.014182:0.005020
ited to a small proportion (10%) of patients with ster-:@0.096344:0.141504:0.480927:0.141504:0.480927:0.125721:0.096344:0.125721:0.003024:0.005125:0.009827:0.010357:0.004914:0.005125:0.009903:0.004914:0.010326:0.004914:0.005866:0.014182:0.010326:0.003024:0.003024:0.004929:0.010311:0.004551:0.009903:0.010311:0.009903:0.004551:0.005125:0.003024:0.009903:0.009223:0.004899:0.005579:0.008376:0.008376:0.011717:0.005579:0.004929:0.009903:0.004747:0.004914:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004914:0.012564:0.003024:0.005125:0.009223:0.004914:0.005866:0.005125:0.009827:0.004551:0.005020
oid-resistant asthma.:@0.096344:0.155647:0.247005:0.155647:0.247005:0.139865:0.096344:0.139865:0.009903:0.003024:0.010357:0.005020:0.004551:0.009827:0.005866:0.003024:0.005866:0.005125:0.010326:0.009223:0.005125:0.004188:0.010326:0.005866:0.005125:0.009223:0.014182:0.010326:0.004188
WHen tO refer:@0.076190:0.188544:0.211825:0.188544:0.211825:0.168379:0.076190:0.168379:0.016631:0.012566:0.009609:0.013674:0.005174:0.007761:0.015522:0.005174:0.010718:0.009609:0.008870:0.009609:0.010718
2,4,14:@0.211813:0.182068:0.241823:0.182068:0.241823:0.170372:0.211813:0.170372:0.006002:0.003001:0.006002:0.003001:0.006002:0.006002
Referral of the patient to a specialist is required if he/she :@0.076190:0.204466:0.485130:0.204466:0.485130:0.188684:0.076190:0.188684:0.009177:0.009827:0.004747:0.009827:0.004551:0.004551:0.010326:0.003024:0.003644:0.009903:0.004747:0.003644:0.005125:0.009223:0.009827:0.003644:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.003659:0.005125:0.009903:0.003644:0.010326:0.003659:0.005866:0.010311:0.009827:0.009782:0.003024:0.010326:0.003024:0.003024:0.005866:0.005125:0.003674:0.003024:0.005866:0.003659:0.004551:0.009827:0.010311:0.009192:0.003024:0.004551:0.009827:0.010357:0.003644:0.003024:0.004747:0.003659:0.009223:0.009827:0.006607:0.005866:0.009223:0.009827:0.004188
presents with the following conditions.:@0.076190:0.218609:0.352854:0.218609:0.352854:0.202827:0.076190:0.202827:0.010311:0.004551:0.009827:0.005866:0.009827:0.009223:0.005125:0.005866:0.004188:0.012564:0.003024:0.005125:0.009223:0.004188:0.005125:0.009223:0.009827:0.004188:0.004747:0.009903:0.003024:0.003024:0.009903:0.012564:0.003024:0.009223:0.010175:0.004188:0.009782:0.009903:0.009223:0.010357:0.003024:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188
•  Diagnostic uncertainty:@0.076190:0.232753:0.261731:0.232753:0.261731:0.216970:0.076190:0.216970:0.009162:0.004188:0.006804:0.011249:0.003024:0.010326:0.010175:0.009223:0.009903:0.005866:0.005125:0.003024:0.009782:0.004188:0.009192:0.009223:0.009782:0.009827:0.004551:0.005125:0.010326:0.003024:0.009223:0.005125:0.008104
•  If, after four to six hours, the bronchospasm is not re:@0.076190:0.246896:0.475923:0.246896:0.475923:0.231113:0.076190:0.231113:0.009162:0.004188:0.006804:0.003417:0.004747:0.004188:0.004899:0.010326:0.004747:0.005125:0.009827:0.004551:0.004899:0.004747:0.009903:0.009192:0.004551:0.004899:0.005125:0.009903:0.004899:0.005866:0.003024:0.007257:0.004914:0.009223:0.009903:0.009192:0.004551:0.005866:0.004188:0.004899:0.005125:0.009223:0.009827:0.004899:0.010311:0.004551:0.009903:0.009223:0.009782:0.009223:0.009903:0.005866:0.010311:0.010326:0.005866:0.014182:0.004899:0.003024:0.005866:0.004914:0.009223:0.009903:0.005125:0.004899:0.004551:0.009827
-:@0.475923:0.246896:0.480942:0.246896:0.480942:0.231113:0.475923:0.231113:0.005020
sponding to reliever medications.:@0.096344:0.261039:0.339851:0.261039:0.339851:0.245256:0.096344:0.245256:0.005866:0.010311:0.009903:0.009223:0.010357:0.003024:0.009223:0.010175:0.004188:0.005125:0.009903:0.004188:0.004551:0.009827:0.003024:0.003024:0.009827:0.008376:0.009827:0.004551:0.004188:0.014182:0.009827:0.010357:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188
•  When the bronchospasm is associated with cardio:@0.076190:0.275182:0.475907:0.275182:0.475907:0.259400:0.076190:0.259400:0.009162:0.004188:0.006804:0.014514:0.009223:0.009827:0.009223:0.005987:0.005125:0.009223:0.009827:0.006002:0.010311:0.004551:0.009903:0.009223:0.009782:0.009223:0.009903:0.005866:0.010311:0.010326:0.005866:0.014182:0.005987:0.003024:0.005866:0.006002:0.010326:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.009827:0.010357:0.006002:0.012564:0.003024:0.005125:0.009223:0.006002:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903
-:@0.475907:0.275182:0.480927:0.275182:0.480927:0.259400:0.475907:0.259400:0.005020
vascular collapse or has serious concomitant cardi-:@0.096344:0.289325:0.480957:0.289325:0.480957:0.273543:0.096344:0.273543:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.005730:0.009782:0.009903:0.003024:0.003024:0.010326:0.010311:0.005866:0.009827:0.005730:0.009903:0.004551:0.005715:0.009223:0.010326:0.005866:0.005730:0.005866:0.009827:0.004551:0.003024:0.009903:0.009192:0.005866:0.005730:0.009782:0.009903:0.009223:0.009782:0.009903:0.014182:0.003024:0.005125:0.010326:0.009223:0.005125:0.005715:0.009782:0.010326:0.004551:0.010357:0.003024:0.005020
ac complications.:@0.096344:0.303469:0.228303:0.303469:0.228303:0.287686:0.096344:0.287686:0.010326:0.009782:0.004188:0.009782:0.009903:0.014182:0.010311:0.003024:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188
•  If the bronchospasm is caused by a pulmonary em:@0.076190:0.317612:0.475907:0.317612:0.475907:0.301829:0.076190:0.301829:0.009162:0.004188:0.006804:0.003417:0.004747:0.005246:0.005125:0.009223:0.009827:0.005246:0.010311:0.004551:0.009903:0.009223:0.009782:0.009223:0.009903:0.005866:0.010311:0.010326:0.005866:0.014182:0.005246:0.003024:0.005866:0.005246:0.009782:0.010326:0.009192:0.005866:0.009827:0.010357:0.005246:0.010311:0.008104:0.005246:0.010326:0.005246:0.010311:0.009192:0.003024:0.014182:0.009903:0.009223:0.010326:0.004551:0.008104:0.005246:0.009827:0.014182
-:@0.475907:0.317612:0.480927:0.317612:0.480927:0.301829:0.475907:0.301829:0.005020
bolism.:@0.096344:0.331755:0.146842:0.331755:0.146842:0.315972:0.096344:0.315972:0.010311:0.009903:0.003024:0.003024:0.005866:0.014182:0.004188
•  When the bronchospasm is associated with other co:@0.076190:0.345898:0.475923:0.345898:0.475923:0.330115:0.076190:0.330115:0.009162:0.004188:0.006804:0.014514:0.009223:0.009827:0.009223:0.003659:0.005125:0.009223:0.009827:0.003659:0.010311:0.004551:0.009903:0.009223:0.009782:0.009223:0.009903:0.005866:0.010311:0.010326:0.005866:0.014182:0.003659:0.003024:0.005866:0.003674:0.010326:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.009827:0.010357:0.003674:0.012564:0.003024:0.005125:0.009223:0.003659:0.009903:0.005125:0.009223:0.009827:0.004551:0.003644:0.009782:0.009903
-:@0.475923:0.345898:0.480942:0.345898:0.480942:0.330115:0.475923:0.330115:0.005020
morbidities.:@0.096344:0.360041:0.179726:0.360041:0.179726:0.344259:0.096344:0.344259:0.014182:0.009903:0.004551:0.010311:0.003024:0.010357:0.003024:0.005125:0.003024:0.009827:0.005866:0.004188
•  Bronchospasm  associated  with  impending  respira:@0.076190:0.374184:0.475923:0.374184:0.475923:0.358402:0.076190:0.358402:0.009162:0.004188:0.006804:0.008678:0.004551:0.009903:0.009223:0.009782:0.009223:0.009903:0.005866:0.010311:0.010326:0.005866:0.014182:0.004188:0.004218:0.010326:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.009827:0.010357:0.004188:0.004218:0.012564:0.003024:0.005125:0.009223:0.004188:0.004218:0.003024:0.014182:0.010311:0.009827:0.009223:0.010357:0.003024:0.009223:0.010175:0.004188:0.004218:0.004551:0.009827:0.005866:0.010311:0.003024:0.004551:0.010326
-:@0.475923:0.374184:0.480942:0.374184:0.480942:0.358402:0.475923:0.358402:0.005020
tory failure/respiratory arrest.:@0.096344:0.388328:0.304276:0.388328:0.304276:0.372545:0.096344:0.372545:0.005125:0.009903:0.004551:0.008104:0.004188:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.006607:0.004551:0.009827:0.005866:0.010311:0.003024:0.004551:0.010326:0.005125:0.009903:0.004551:0.008104:0.004188:0.010326:0.004551:0.004551:0.009827:0.005866:0.005125:0.004188
•  Airflow obstruction associated with mental confusion.:@0.076190:0.402471:0.480942:0.402471:0.480942:0.386688:0.076190:0.386688:0.009162:0.004188:0.006804:0.011188:0.003024:0.004551:0.003666:0.003666:0.009903:0.012564:0.003387:0.009903:0.010311:0.005866:0.005125:0.004551:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.003387:0.010326:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.009827:0.010357:0.003387:0.012564:0.003024:0.005125:0.009223:0.003387:0.014182:0.009827:0.009223:0.005125:0.010326:0.003024:0.003387:0.009782:0.009903:0.009223:0.004747:0.009192:0.005866:0.003024:0.009903:0.009223:0.004188
•  Any patient with severe airflow obstruction who de:@0.076190:0.416614:0.475923:0.416614:0.475923:0.400831:0.076190:0.400831:0.009162:0.004188:0.006804:0.011188:0.009223:0.008104:0.005473:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005473:0.012564:0.003024:0.005125:0.009223:0.005473:0.005866:0.009827:0.008376:0.009827:0.004551:0.009827:0.005473:0.010326:0.003024:0.004551:0.003666:0.003666:0.009903:0.012564:0.005473:0.009903:0.010311:0.005866:0.005125:0.004551:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.005473:0.012564:0.009223:0.009903:0.005473:0.010357:0.009827
-:@0.475923:0.416614:0.480942:0.416614:0.480942:0.400831:0.475923:0.400831:0.005020
teriorates despite adequate therapy.:@0.096344:0.430757:0.368320:0.430757:0.368320:0.414974:0.096344:0.414974:0.005125:0.009827:0.004551:0.003024:0.009903:0.004551:0.010326:0.005125:0.009827:0.005866:0.004188:0.010357:0.009827:0.005866:0.010311:0.003024:0.005125:0.009827:0.004188:0.010326:0.010357:0.009827:0.010311:0.009192:0.010326:0.005125:0.009827:0.004188:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188
•  Inadequacy of support and home conditions.:@0.076190:0.444900:0.430717:0.444900:0.430717:0.429118:0.076190:0.429118:0.009162:0.004188:0.006804:0.003417:0.009223:0.010326:0.010357:0.009827:0.010311:0.009192:0.010326:0.009782:0.008104:0.004188:0.009903:0.004747:0.004188:0.005866:0.009192:0.010311:0.010311:0.009903:0.004551:0.005125:0.004188:0.010326:0.009223:0.010357:0.004188:0.009223:0.009903:0.014182:0.009827:0.004188:0.009782:0.009903:0.009223:0.010357:0.003024:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188
•  Cause and severity of prior exacerbations, e.g. ICU :@0.076190:0.459043:0.485130:0.459043:0.485130:0.443261:0.076190:0.443261:0.009162:0.004188:0.006804:0.012292:0.010326:0.009192:0.005866:0.009827:0.006002:0.010326:0.009223:0.010357:0.006002:0.005866:0.009827:0.008376:0.009827:0.004551:0.003024:0.005125:0.008104:0.006002:0.009903:0.004747:0.006002:0.010311:0.004551:0.003024:0.009903:0.004551:0.005987:0.009827:0.007257:0.010326:0.009782:0.009827:0.004551:0.010311:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188:0.005987:0.009827:0.004188:0.010175:0.004188:0.005987:0.003417:0.012292:0.009903:0.004188
admission and/or intubation.:@0.096344:0.473187:0.306121:0.473187:0.306121:0.457404:0.096344:0.457404:0.010326:0.010357:0.014182:0.003024:0.005866:0.005866:0.003024:0.009903:0.009223:0.004188:0.010326:0.009223:0.010357:0.006607:0.009903:0.004551:0.004188:0.003024:0.009223:0.005125:0.009192:0.010311:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188
referenCes:@0.076190:0.506098:0.182628:0.506098:0.182628:0.485933:0.076190:0.485933:0.010718:0.009609:0.008870:0.009609:0.010718:0.009609:0.013674:0.014413:0.009609:0.009609
1. :@0.076190:0.518026:0.088984:0.518026:0.088984:0.505750:0.076190:0.505750:0.006397:0.003140:0.003257
Doeing DC, solway J. Airway smooth muscle in the pathophysiology :@0.101390:0.518026:0.484201:0.518026:0.484201:0.505750:0.101390:0.505750:0.008631:0.007585:0.007526:0.002234:0.007056:0.007796:0.003222:0.008631:0.009443:0.003140:0.003234:0.005739:0.007585:0.002234:0.009654:0.007914:0.006185:0.003222:0.005550:0.003140:0.003222:0.008584:0.002234:0.003422:0.009654:0.007914:0.006185:0.003222:0.004445:0.010913:0.007585:0.007585:0.003869:0.007056:0.003234:0.010913:0.007032:0.004445:0.007491:0.002234:0.007526:0.003222:0.002234:0.007056:0.003234:0.003869:0.007056:0.007526:0.003222:0.007902:0.007914:0.003869:0.007056:0.007585:0.007902:0.007056:0.006185:0.004445:0.002234:0.007585:0.002234:0.007585:0.007796:0.006303:0.003257
and treatment of asthma. :@0.101390:0.528963:0.249345:0.528963:0.249345:0.516688:0.101390:0.516688:0.007914:0.007056:0.007937:0.003140:0.003869:0.003422:0.007526:0.007914:0.003869:0.010913:0.007526:0.007056:0.003869:0.003140:0.007585:0.003575:0.003140:0.007914:0.004445:0.003869:0.007056:0.010913:0.007914:0.003140:0.003257
J Appl Physiol:@0.249228:0.528963:0.324381:0.528963:0.324381:0.516688:0.249228:0.516688:0.005550:0.003140:0.008584:0.007902:0.007902:0.002234:0.003140:0.006844:0.007056:0.006185:0.004445:0.002234:0.007585:0.002352
. 2013;114(7):834-843.:@0.324264:0.528963:0.441868:0.528963:0.441868:0.516688:0.324264:0.516688:0.003140:0.003140:0.006397:0.006397:0.006397:0.006397:0.003140:0.006397:0.006397:0.006397:0.004222:0.006397:0.004222:0.003140:0.006397:0.006397:0.006397:0.003786:0.006397:0.006397:0.006397:0.003257
2. :@0.076190:0.539900:0.089220:0.539900:0.089220:0.527625:0.076190:0.527625:0.006515:0.003257:0.003257
Global Initiative for Asthma. Global strategy for asthma manage-:@0.101390:0.539900:0.480956:0.539900:0.480956:0.527625:0.101390:0.527625:0.010254:0.002352:0.007702:0.008020:0.008032:0.002352:0.004504:0.002658:0.007173:0.002352:0.003986:0.002352:0.008032:0.003986:0.002352:0.006515:0.007644:0.004504:0.003692:0.007702:0.003540:0.004492:0.008702:0.004563:0.003986:0.007173:0.011030:0.008032:0.003257:0.004492:0.010254:0.002352:0.007702:0.008020:0.008032:0.002352:0.004504:0.004563:0.003986:0.003540:0.008032:0.003986:0.007644:0.007914:0.006303:0.004492:0.003692:0.007702:0.003540:0.004492:0.008032:0.004563:0.003986:0.007173:0.011030:0.008032:0.004492:0.011030:0.008032:0.007173:0.008032:0.007914:0.007644:0.003904
ment  and  prevention.  2018. Available from:  www.ginasthma.org. :@0.101390:0.550838:0.484213:0.550838:0.484213:0.538562:0.101390:0.538562:0.011030:0.007644:0.007173:0.003986:0.003257:0.001811:0.008032:0.007173:0.008055:0.003257:0.001811:0.008020:0.003540:0.007644:0.006515:0.007644:0.007173:0.003986:0.002352:0.007702:0.007173:0.003257:0.003257:0.001811:0.006515:0.006515:0.006515:0.006515:0.003257:0.005080:0.008702:0.006515:0.008032:0.002352:0.002352:0.008032:0.008020:0.002352:0.007644:0.005080:0.003692:0.003540:0.007702:0.011030:0.003257:0.003257:0.001811:0.009772:0.009772:0.009772:0.003257:0.007914:0.002352:0.007173:0.008032:0.004563:0.003986:0.007173:0.011030:0.008032:0.003257:0.007702:0.003540:0.007914:0.003257:0.003257
Accessed December 18, 2018.:@0.101390:0.561775:0.275028:0.561775:0.275028:0.549500:0.101390:0.549500:0.008702:0.007608:0.007608:0.007644:0.004563:0.004563:0.007644:0.008055:0.003257:0.008749:0.007644:0.007608:0.007644:0.011030:0.008020:0.007644:0.003540:0.003257:0.006515:0.006515:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257
3. :@0.076190:0.572713:0.088749:0.572713:0.088749:0.560437:0.076190:0.560437:0.006279:0.003022:0.003257
Zar HJ, Lalloo UG. Acute asthma treatment guidelines: Reducing mor-:@0.101390:0.572713:0.480944:0.572713:0.480944:0.560437:0.101390:0.560437:0.005409:0.007796:0.003304:0.003046:0.007796:0.005433:0.003022:0.003046:0.005198:0.007796:0.002117:0.002117:0.007467:0.007467:0.003046:0.007467:0.010019:0.003022:0.003046:0.008467:0.007373:0.006914:0.003751:0.007408:0.003046:0.007796:0.004327:0.003751:0.006938:0.010795:0.007796:0.003046:0.003751:0.003304:0.007408:0.007796:0.003751:0.010795:0.007408:0.006938:0.003751:0.003046:0.007679:0.006914:0.002117:0.007820:0.007408:0.002117:0.002117:0.006938:0.007408:0.004327:0.003022:0.003046:0.006903:0.007408:0.007820:0.006914:0.007373:0.002117:0.006938:0.007679:0.003046:0.010795:0.007467:0.003304:0.003904
bidity and mortality in south Africa. :@0.101390:0.583650:0.294419:0.583650:0.294419:0.571375:0.101390:0.571375:0.007785:0.002117:0.007820:0.002117:0.003751:0.006068:0.003022:0.007796:0.006938:0.007820:0.003022:0.010795:0.007467:0.003304:0.003751:0.007796:0.002117:0.002117:0.003751:0.006068:0.003022:0.002117:0.006938:0.003022:0.005621:0.007467:0.006914:0.003751:0.006938:0.003022:0.008467:0.003457:0.003304:0.002117:0.007373:0.007796:0.003022:0.003257
S Afr Med J.:@0.294183:0.583650:0.358589:0.583650:0.358589:0.571375:0.294183:0.571375:0.005621:0.003022:0.008467:0.003457:0.003304:0.003022:0.010572:0.007408:0.007820:0.003022:0.005433:0.003257
 2013;103(3):159-160.:@0.358354:0.583650:0.470466:0.583650:0.470466:0.571375:0.358354:0.571375:0.003022:0.006279:0.006279:0.006279:0.006279:0.003022:0.006279:0.006279:0.006279:0.004104:0.006279:0.004104:0.003022:0.006279:0.006279:0.006279:0.003669:0.006279:0.006279:0.006279:0.003257
4. :@0.076190:0.594587:0.089220:0.594587:0.089220:0.582312:0.076190:0.582312:0.006515:0.003257:0.003257
Lalloo UG, Ainslie AG, Abdool-Gaffar As. Guidelines for the man-:@0.101390:0.594587:0.480956:0.594587:0.480956:0.582312:0.101390:0.582312:0.005433:0.008032:0.002352:0.002352:0.007702:0.007702:0.004727:0.007702:0.010254:0.003257:0.004727:0.008702:0.002352:0.007173:0.004563:0.002352:0.002352:0.007644:0.004727:0.008702:0.010254:0.003257:0.004727:0.008702:0.008020:0.008055:0.007702:0.007702:0.002352:0.003904:0.010254:0.008032:0.003692:0.003692:0.008032:0.003540:0.004727:0.008702:0.005856:0.003257:0.004727:0.010254:0.007150:0.002352:0.008055:0.007644:0.002352:0.002352:0.007173:0.007644:0.004563:0.004727:0.003692:0.007702:0.003540:0.004715:0.003986:0.007173:0.007644:0.004715:0.011030:0.008032:0.007173:0.003904
agement  of acute asthma in adults: 2013  update. :@0.101390:0.605525:0.404756:0.605525:0.404756:0.593249:0.101390:0.593249:0.008032:0.007914:0.007644:0.011030:0.007644:0.007173:0.003986:0.003257:0.002293:0.007702:0.003692:0.005562:0.008032:0.007608:0.007150:0.003986:0.007644:0.005562:0.008032:0.004563:0.003986:0.007173:0.011030:0.008032:0.005562:0.002352:0.007173:0.005562:0.008032:0.008055:0.007150:0.002352:0.003986:0.004563:0.003257:0.005562:0.006515:0.006515:0.006515:0.006515:0.003257:0.002317:0.007150:0.008020:0.008055:0.008032:0.003986:0.007644:0.003257:0.003257
S Afr  Med J. :@0.407060:0.605525:0.484213:0.605525:0.484213:0.593249:0.407060:0.593249:0.005856:0.005562:0.008702:0.003692:0.003540:0.003257:0.002293:0.010807:0.007644:0.008055:0.005562:0.005668:0.003257:0.003257
2013;103(3):189-198.:@0.101390:0.616462:0.214950:0.616462:0.214950:0.604187:0.101390:0.604187:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
5. :@0.076190:0.627400:0.089220:0.627400:0.089220:0.615124:0.076190:0.615124:0.006515:0.003257:0.003257
Gherasim A, Dao A, Bernstein JA. Confounders of severe asthma: :@0.101390:0.627400:0.484201:0.627400:0.484201:0.615124:0.101390:0.615124:0.010254:0.007173:0.007644:0.003540:0.008032:0.004563:0.002352:0.011030:0.004351:0.008702:0.003257:0.004351:0.008749:0.008032:0.007702:0.004351:0.008702:0.003257:0.004351:0.006750:0.007644:0.003540:0.007173:0.004563:0.003986:0.007644:0.002352:0.007173:0.004351:0.005668:0.008702:0.003257:0.004351:0.009560:0.007702:0.007173:0.003692:0.007702:0.007150:0.007173:0.008055:0.007644:0.003540:0.004563:0.004339:0.007702:0.003692:0.004351:0.004563:0.007644:0.006515:0.007644:0.003540:0.007644:0.004351:0.008032:0.004563:0.003986:0.007173:0.011030:0.008032:0.003257:0.003257
diagnoses to consider when asthma symptoms persist despite opti-:@0.101390:0.638337:0.480956:0.638337:0.480956:0.626062:0.101390:0.626062:0.008055:0.002352:0.008032:0.007914:0.007173:0.007702:0.004563:0.007644:0.004563:0.003328:0.003986:0.007702:0.003316:0.007608:0.007702:0.007173:0.004563:0.002352:0.008055:0.007644:0.003540:0.003316:0.009772:0.007173:0.007644:0.007173:0.003316:0.008032:0.004563:0.003986:0.007173:0.011030:0.008032:0.003328:0.004563:0.006303:0.011030:0.008020:0.003986:0.007702:0.011030:0.004563:0.003316:0.008020:0.007644:0.003540:0.004563:0.002352:0.004563:0.003986:0.003328:0.008055:0.007644:0.004563:0.008020:0.002352:0.003986:0.007644:0.003328:0.007702:0.008020:0.003986:0.002352:0.003904
mal therapy. :@0.101390:0.649274:0.177273:0.649274:0.177273:0.636999:0.101390:0.636999:0.011030:0.008032:0.002352:0.003257:0.003986:0.007173:0.007644:0.003540:0.008032:0.008020:0.006303:0.003257:0.003257
World Allergy Organ J. :@0.177273:0.649274:0.307848:0.649274:0.307848:0.636999:0.177273:0.636999:0.011289:0.007702:0.003540:0.002352:0.008055:0.003257:0.008702:0.002352:0.002352:0.007644:0.003540:0.007914:0.006303:0.003257:0.010219:0.003540:0.007914:0.008032:0.007173:0.003257:0.005668:0.003257:0.003257
2018;11(1):29.:@0.307824:0.649274:0.384906:0.649274:0.384906:0.636999:0.307824:0.636999:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.003257
6. :@0.076190:0.660212:0.089220:0.660212:0.089220:0.647936:0.076190:0.647936:0.006515:0.003257:0.003257
Masekela R, Gray CL, Green  RJ, :@0.101390:0.660212:0.295571:0.660212:0.295571:0.647936:0.101390:0.647936:0.010807:0.008032:0.004563:0.007644:0.005903:0.007644:0.002352:0.008032:0.005374:0.007138:0.003257:0.005374:0.010254:0.003540:0.008032:0.006303:0.005374:0.009560:0.005433:0.003257:0.005374:0.010254:0.003540:0.007644:0.007644:0.007173:0.003257:0.002105:0.007138:0.005668:0.003257:0.003257
et al.:@0.297688:0.660212:0.328332:0.660212:0.328332:0.647936:0.297688:0.647936:0.007644:0.003986:0.005374:0.008032:0.002352:0.003257
 The  increasing burden of :@0.328332:0.660212:0.484225:0.660212:0.484225:0.647936:0.328332:0.647936:0.005374:0.005009:0.007173:0.007644:0.003257:0.002105:0.002352:0.007173:0.007608:0.003540:0.007644:0.008032:0.004563:0.002352:0.007173:0.007914:0.005374:0.008020:0.007150:0.003540:0.008055:0.007644:0.007173:0.005374:0.007702:0.003692:0.003257
asthma in  south  African children: a call to action. :@0.101390:0.671149:0.404426:0.671149:0.404426:0.658874:0.101390:0.658874:0.008032:0.004563:0.003986:0.007173:0.011030:0.008032:0.005644:0.002352:0.007173:0.003257:0.002387:0.005856:0.007702:0.007150:0.003986:0.007173:0.003257:0.002375:0.008702:0.003692:0.003540:0.002352:0.007608:0.008032:0.007173:0.005644:0.007608:0.007173:0.002352:0.002352:0.008055:0.003540:0.007644:0.007173:0.003257:0.005644:0.008032:0.005644:0.007608:0.008032:0.002352:0.002352:0.005644:0.003986:0.007702:0.005644:0.008032:0.007608:0.003986:0.002352:0.007702:0.007173:0.003257:0.003257
S Afr  Med J. :@0.406813:0.671149:0.484213:0.671149:0.484213:0.658874:0.406813:0.658874:0.005856:0.005644:0.008702:0.003692:0.003540:0.003257:0.002375:0.010807:0.007644:0.008055:0.005644:0.005668:0.003257:0.003257
2018;108(7):537-539. :@0.101390:0.682086:0.218207:0.682086:0.218207:0.669811:0.101390:0.669811:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257:0.003257
7. :@0.076190:0.693024:0.089220:0.693024:0.089220:0.680748:0.076190:0.680748:0.006515:0.003257:0.003257
Aboussouan Ls, stoller JK. Flow-volume loops. In: UpToDate, post TW :@0.101390:0.693024:0.484213:0.693024:0.484213:0.680748:0.101390:0.680748:0.008702:0.008020:0.007702:0.007150:0.004563:0.004563:0.007702:0.007150:0.008032:0.007173:0.002975:0.005433:0.005856:0.003257:0.002987:0.005856:0.003986:0.007702:0.002352:0.002352:0.007644:0.003540:0.002987:0.005668:0.006950:0.003257:0.002975:0.005703:0.002352:0.007702:0.009772:0.003904:0.006515:0.007702:0.002352:0.007150:0.011030:0.007644:0.002987:0.002352:0.007702:0.007702:0.008020:0.004563:0.003257:0.002987:0.002658:0.007173:0.003257:0.002987:0.007702:0.008020:0.005009:0.007702:0.008749:0.008032:0.003986:0.007644:0.003257:0.002975:0.006961:0.007702:0.004563:0.003986:0.002975:0.005009:0.011289:0.003257
(Ed), UpToDate, Waltham, MA. Accessed on January 25, 2019. :@0.101390:0.703961:0.457778:0.703961:0.457778:0.691686:0.101390:0.691686:0.004339:0.006303:0.008055:0.004339:0.003257:0.003257:0.007702:0.008020:0.005009:0.007702:0.008749:0.008032:0.003986:0.007644:0.003257:0.003257:0.011289:0.008032:0.002352:0.003986:0.007173:0.008032:0.011030:0.003257:0.003257:0.010807:0.008702:0.003257:0.003257:0.008702:0.007608:0.007608:0.007644:0.004563:0.004563:0.007644:0.008055:0.003257:0.007702:0.007173:0.003257:0.005668:0.008032:0.007173:0.007150:0.008032:0.003540:0.006303:0.003257:0.006515:0.006515:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257
8. :@0.076190:0.714899:0.089220:0.714899:0.089220:0.702623:0.076190:0.702623:0.006515:0.003257:0.003257
Robinson Ds. The role of the T cell in asthma. :@0.101390:0.714899:0.353685:0.714899:0.353685:0.702623:0.101390:0.702623:0.007138:0.007702:0.008020:0.002352:0.007173:0.004563:0.007702:0.007173:0.003057:0.008749:0.005856:0.003257:0.003057:0.005009:0.007173:0.007644:0.003057:0.003540:0.007702:0.002352:0.007644:0.003057:0.007702:0.003692:0.003057:0.003986:0.007173:0.007644:0.003057:0.005009:0.003057:0.007608:0.007644:0.002352:0.002352:0.003069:0.002352:0.007173:0.003057:0.008032:0.004563:0.003986:0.007173:0.011030:0.008032:0.003257:0.003257
J Allergy Clin Immunol. :@0.353509:0.714899:0.484213:0.714899:0.484213:0.702623:0.353509:0.702623:0.005668:0.003057:0.008702:0.002352:0.002352:0.007644:0.003540:0.007914:0.006303:0.003057:0.009560:0.002352:0.002352:0.007173:0.003069:0.002658:0.011030:0.011030:0.007150:0.007173:0.007702:0.002352:0.003257:0.003257
2010;126:1081.:@0.101390:0.725836:0.182823:0.725836:0.182823:0.713561:0.101390:0.713561:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257
9. :@0.076190:0.736773:0.089220:0.736773:0.089220:0.724498:0.076190:0.724498:0.006515:0.003257:0.003257
Antosova  M,  strapkova A,  plevkova J. Bronchial hyper-reactivity: :@0.101390:0.736773:0.484213:0.736773:0.484213:0.724498:0.101390:0.724498:0.008702:0.007173:0.003986:0.007702:0.004563:0.007702:0.006515:0.008032:0.003257:0.001905:0.010807:0.003257:0.003257:0.001917:0.005856:0.003986:0.003540:0.008032:0.008020:0.005903:0.007702:0.006515:0.008032:0.005174:0.008702:0.003257:0.003257:0.001905:0.006961:0.002352:0.007644:0.006515:0.005903:0.007702:0.006515:0.008032:0.005174:0.005668:0.003257:0.005174:0.006750:0.003540:0.007702:0.007173:0.007608:0.007173:0.002352:0.008032:0.002352:0.005174:0.007173:0.006303:0.008020:0.007644:0.003540:0.003904:0.003540:0.007644:0.008032:0.007608:0.003986:0.002352:0.006515:0.002352:0.003986:0.006303:0.003257:0.003257
pathogenesis and treatment options. :@0.101390:0.747711:0.315997:0.747711:0.315997:0.735435:0.101390:0.735435:0.008020:0.008032:0.003986:0.007173:0.007702:0.007914:0.007644:0.007173:0.007644:0.004563:0.002352:0.004563:0.003187:0.008032:0.007173:0.008055:0.003187:0.003986:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.003175:0.007702:0.008020:0.003986:0.002352:0.007702:0.007173:0.004563:0.003257:0.003257
Open J Mol Integrative Physi-:@0.315926:0.747711:0.480956:0.747711:0.480956:0.735435:0.315926:0.735435:0.010219:0.008020:0.007644:0.007173:0.003187:0.005668:0.003187:0.010807:0.007702:0.002352:0.003187:0.002658:0.007173:0.003986:0.007644:0.007914:0.003540:0.008032:0.003986:0.002352:0.006515:0.007644:0.003187:0.006961:0.007173:0.006303:0.004563:0.002352:0.003904
ol.:@0.101390:0.758648:0.114702:0.758648:0.114702:0.746373:0.101390:0.746373:0.007702:0.002352:0.003257
 2011;01;43-56.:@0.114702:0.758648:0.196781:0.758648:0.196781:0.746373:0.114702:0.746373:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
10.  Benca J. Bronchospasm. In: Atlee JL, ed. Complications in anaesthe-:@0.076190:0.769586:0.480944:0.769586:0.480944:0.757310:0.076190:0.757310:0.006515:0.006515:0.003257:0.003257:0.005656:0.006750:0.007644:0.007173:0.007608:0.008032:0.002164:0.005668:0.003257:0.002164:0.006750:0.003540:0.007702:0.007173:0.007608:0.007173:0.007702:0.004563:0.008020:0.008032:0.004563:0.011030:0.003257:0.002164:0.002658:0.007173:0.003257:0.002164:0.008702:0.003986:0.002352:0.007644:0.007644:0.002164:0.005668:0.005433:0.003257:0.002164:0.007644:0.008055:0.003257:0.002164:0.009560:0.007702:0.011030:0.008020:0.002352:0.002352:0.007608:0.008032:0.003986:0.002352:0.007702:0.007173:0.004563:0.002164:0.002352:0.007173:0.002164:0.008032:0.007173:0.008032:0.007644:0.004563:0.003986:0.007173:0.007644:0.003904
sia. second edition. philadelphia: saunders Elsevier;2006:189-192.:@0.101390:0.780523:0.467938:0.780523:0.467938:0.768248:0.101390:0.768248:0.004563:0.002352:0.008032:0.003257:0.003257:0.005856:0.007644:0.007608:0.007702:0.007173:0.008055:0.003257:0.007644:0.008055:0.002352:0.003986:0.002352:0.007702:0.007173:0.003257:0.003257:0.006961:0.007173:0.002352:0.002352:0.008032:0.008055:0.007644:0.002352:0.008020:0.007173:0.002352:0.008032:0.003257:0.003257:0.005856:0.008032:0.007150:0.007173:0.008055:0.007644:0.003540:0.004563:0.003257:0.006303:0.002352:0.004563:0.007644:0.006515:0.002352:0.007644:0.003540:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
11.  Riccio MM, proud D. Evidence that enhanced nasal reactivity to :@0.076190:0.791460:0.484213:0.791460:0.484213:0.779185:0.076190:0.779185:0.006515:0.006515:0.003257:0.003257:0.005656:0.007138:0.002352:0.007608:0.007608:0.002352:0.007702:0.004821:0.010807:0.010807:0.003257:0.004821:0.006961:0.003540:0.007702:0.007150:0.008055:0.004810:0.008749:0.003257:0.004821:0.006303:0.006515:0.002352:0.008055:0.007644:0.007173:0.007608:0.007644:0.004821:0.003986:0.007173:0.008032:0.003986:0.004821:0.007644:0.007173:0.007173:0.008032:0.007173:0.007608:0.007644:0.008055:0.004821:0.007173:0.008032:0.004563:0.008032:0.002352:0.004833:0.003540:0.007644:0.008032:0.007608:0.003986:0.002352:0.006515:0.002352:0.003986:0.006303:0.004821:0.003986:0.007702:0.003257
bradykinin in patients with symptomatic allergy is mediated by neu-:@0.101390:0.802398:0.480944:0.802398:0.480944:0.790122:0.101390:0.790122:0.008020:0.003540:0.008032:0.008055:0.006303:0.005903:0.002352:0.007173:0.002352:0.007173:0.002834:0.002352:0.007173:0.002822:0.008020:0.008032:0.003986:0.002352:0.007644:0.007173:0.003986:0.004563:0.002822:0.009772:0.002352:0.003986:0.007173:0.002822:0.004563:0.006303:0.011030:0.008020:0.003986:0.007702:0.011030:0.008032:0.003986:0.002352:0.007608:0.002822:0.008032:0.002352:0.002352:0.007644:0.003540:0.007914:0.006303:0.002822:0.002352:0.004563:0.002834:0.011030:0.007644:0.008055:0.002352:0.008032:0.003986:0.007644:0.008055:0.002822:0.008020:0.006303:0.002834:0.007173:0.007644:0.007150:0.003904
ral reflexes. :@0.101390:0.813335:0.167466:0.813335:0.167466:0.801060:0.101390:0.801060:0.003540:0.008032:0.002352:0.003257:0.003540:0.007644:0.002852:0.002852:0.007644:0.005644:0.007644:0.004563:0.003257:0.003257
J Allergy Clin Immunol.:@0.167454:0.813335:0.295489:0.813335:0.295489:0.801060:0.167454:0.801060:0.005668:0.003257:0.008702:0.002352:0.002352:0.007644:0.003540:0.007914:0.006303:0.003257:0.009560:0.002352:0.002352:0.007173:0.003257:0.002658:0.011030:0.011030:0.007150:0.007173:0.007702:0.002352:0.003257
1996;97:1252.:@0.295477:0.813335:0.370395:0.813335:0.370395:0.801060:0.295477:0.801060:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257
12.  Rowe BH, Bretzlaff J, Bourdon C, :@0.076190:0.824273:0.287339:0.824273:0.287339:0.811997:0.076190:0.811997:0.006515:0.006515:0.003257:0.003257:0.005656:0.007138:0.007702:0.009772:0.007644:0.003575:0.006750:0.008032:0.003257:0.003587:0.006750:0.003540:0.007644:0.003986:0.004998:0.002352:0.008032:0.003692:0.003692:0.003575:0.005668:0.003257:0.003587:0.006750:0.007702:0.007150:0.003540:0.008055:0.007702:0.007173:0.003575:0.009560:0.003257:0.003257
et al.:@0.287669:0.824273:0.316514:0.824273:0.316514:0.811997:0.287669:0.811997:0.007644:0.003986:0.003575:0.008032:0.002352:0.003257
 Magnesium sulfate for treat-:@0.316514:0.824273:0.480956:0.824273:0.480956:0.811997:0.316514:0.811997:0.003587:0.010807:0.008032:0.007914:0.007173:0.007644:0.004563:0.002352:0.007150:0.011030:0.003587:0.004563:0.007150:0.002352:0.003692:0.008032:0.003986:0.007644:0.003587:0.003692:0.007702:0.003540:0.003575:0.003986:0.003540:0.007644:0.008032:0.003986:0.003904
ing exacerbations of acute asthma in the emergency department. :@0.101390:0.835210:0.484213:0.835210:0.484213:0.822935:0.101390:0.822935:0.002352:0.007173:0.007914:0.003046:0.007644:0.005644:0.008032:0.007608:0.007644:0.003540:0.008020:0.008032:0.003986:0.002352:0.007702:0.007173:0.004563:0.003046:0.007702:0.003692:0.003046:0.008032:0.007608:0.007150:0.003986:0.007644:0.003046:0.008032:0.004563:0.003986:0.007173:0.011030:0.008032:0.003046:0.002352:0.007173:0.003046:0.003986:0.007173:0.007644:0.003046:0.007644:0.011030:0.007644:0.003540:0.007914:0.007644:0.007173:0.007608:0.006303:0.003046:0.008055:0.007644:0.008020:0.008032:0.003540:0.003986:0.011030:0.007644:0.007173:0.003986:0.003257:0.003257
Cochrane Database of systematic Reviews. 2000; Issue 1. Art. No.: :@0.101390:0.846147:0.484225:0.846147:0.484225:0.833872:0.101390:0.833872:0.009560:0.007702:0.007608:0.007173:0.003540:0.008032:0.007173:0.007644:0.003810:0.008749:0.008032:0.003986:0.008032:0.008020:0.008032:0.004574:0.007644:0.003822:0.007702:0.003692:0.003822:0.005856:0.006303:0.004563:0.003986:0.007644:0.011030:0.008032:0.003986:0.002352:0.007608:0.003822:0.007138:0.007644:0.006515:0.002352:0.007644:0.009772:0.004563:0.003257:0.003822:0.006515:0.006515:0.006515:0.006515:0.003257:0.003822:0.002658:0.004563:0.004563:0.007150:0.007644:0.003822:0.006515:0.003257:0.003822:0.008702:0.003540:0.003986:0.003257:0.003810:0.008702:0.007702:0.003257:0.003257:0.003257
CD001490. DOI: 10.1002/14651858.CD001490.:@0.101390:0.857085:0.356954:0.857085:0.356954:0.844809:0.101390:0.844809:0.009560:0.008749:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257:0.008749:0.010219:0.002658:0.003257:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.006515:0.005139:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.003257:0.009560:0.008749:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.003257
13.  peebles Rs Jr, permutt s, Togio sA. Rapid reversibility of the allergen-:@0.076190:0.868022:0.480944:0.868022:0.480944:0.855747:0.076190:0.855747:0.006515:0.006515:0.003257:0.003257:0.005656:0.006961:0.007644:0.007644:0.008020:0.002352:0.007644:0.004563:0.002893:0.007138:0.005856:0.002893:0.005668:0.003540:0.003257:0.002905:0.006961:0.007644:0.003540:0.011030:0.007150:0.003986:0.003986:0.002893:0.005856:0.003257:0.002893:0.005009:0.007702:0.007914:0.002352:0.007702:0.002893:0.005856:0.008702:0.003257:0.002893:0.007138:0.008032:0.008020:0.002352:0.008055:0.002905:0.003540:0.007644:0.006515:0.007644:0.003540:0.004563:0.002352:0.008020:0.002352:0.002352:0.002352:0.003986:0.006303:0.002905:0.007702:0.003692:0.002893:0.003986:0.007173:0.007644:0.002893:0.008032:0.002352:0.002352:0.007644:0.003540:0.007914:0.007644:0.007173:0.003904
induced pulmonary late phase reaction by an intravenous beta2-:@0.101390:0.878959:0.480956:0.878959:0.480956:0.866684:0.101390:0.866684:0.002352:0.007173:0.008055:0.007150:0.007608:0.007644:0.008055:0.003916:0.008020:0.007150:0.002352:0.011030:0.007702:0.007173:0.008032:0.003540:0.006303:0.003904:0.002352:0.008032:0.003986:0.007644:0.003916:0.008020:0.007173:0.008032:0.004563:0.007644:0.003916:0.003540:0.007644:0.008032:0.007608:0.003986:0.002352:0.007702:0.007173:0.003904:0.008020:0.006303:0.003916:0.008032:0.007173:0.003916:0.002352:0.007173:0.003986:0.003540:0.008032:0.006515:0.007644:0.007173:0.007702:0.007150:0.004563:0.003904:0.008020:0.007644:0.003986:0.008032:0.006515:0.003904
agonist. :@0.101390:0.889897:0.149627:0.889897:0.149627:0.877621:0.101390:0.877621:0.008032:0.007914:0.007702:0.007173:0.002352:0.004563:0.003986:0.003257:0.003257
J Appl Physiol.:@0.149627:0.889897:0.229566:0.889897:0.229566:0.877621:0.149627:0.877621:0.005668:0.003257:0.008702:0.008020:0.008020:0.002352:0.003257:0.006961:0.007173:0.006303:0.004563:0.002352:0.007702:0.002352:0.003257
 (1985) 1998;84:1500.:@0.229566:0.889897:0.345736:0.889897:0.345736:0.877621:0.229566:0.877621:0.003257:0.004339:0.006515:0.006515:0.006515:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257
14.  price D, Bjermer L, Bergin DA. Asthma referrals: A key component :@0.076190:0.900834:0.484236:0.900834:0.484236:0.888559:0.076190:0.888559:0.006515:0.006515:0.003257:0.003257:0.005656:0.006961:0.003540:0.002352:0.007608:0.007644:0.004421:0.008749:0.003257:0.004433:0.006750:0.002387:0.007644:0.003540:0.011030:0.007644:0.003540:0.004433:0.005433:0.003257:0.004433:0.006750:0.007644:0.003540:0.007914:0.002352:0.007173:0.004433:0.008749:0.008702:0.003257:0.004421:0.008702:0.004563:0.003986:0.007173:0.011030:0.008032:0.004433:0.003540:0.007644:0.003692:0.007644:0.003540:0.003540:0.008032:0.002352:0.004563:0.003257:0.004421:0.008702:0.004433:0.005903:0.007644:0.006303:0.004433:0.007608:0.007702:0.011030:0.008020:0.007702:0.007173:0.007644:0.007173:0.003986:0.003257
of asthma management that needs to be addressed. :@0.101390:0.911772:0.410318:0.911772:0.410318:0.899496:0.101390:0.899496:0.007702:0.003692:0.003257:0.008032:0.004563:0.003986:0.007173:0.011030:0.008032:0.003257:0.011030:0.008032:0.007173:0.008032:0.007914:0.007644:0.011030:0.007644:0.007173:0.003986:0.003246:0.003986:0.007173:0.008032:0.003986:0.003257:0.007173:0.007644:0.007644:0.008055:0.004563:0.003257:0.003986:0.007702:0.003257:0.008020:0.007644:0.003257:0.008032:0.008055:0.008055:0.003540:0.007644:0.004563:0.004563:0.007644:0.008055:0.003257:0.003257
J Asthma Al-:@0.410318:0.911772:0.480944:0.911772:0.480944:0.899496:0.410318:0.899496:0.005668:0.003257:0.008702:0.004563:0.003986:0.007173:0.011030:0.008032:0.003257:0.008702:0.002352:0.003904
lergy. :@0.101390:0.922709:0.135657:0.922709:0.135657:0.910434:0.101390:0.910434:0.002352:0.007644:0.003540:0.007914:0.006303:0.003257:0.003257
2017;10:209-223.:@0.135657:0.922709:0.227508:0.922709:0.227508:0.910434:0.135657:0.910434:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
15.  Ash sY, Diaz sJ. The role of imaging in assessment of severe asthma. :@0.076190:0.933646:0.484189:0.933646:0.484189:0.921371:0.076190:0.921371:0.006515:0.006515:0.003257:0.003257:0.005656:0.008702:0.004563:0.007173:0.003046:0.005856:0.006961:0.003257:0.003046:0.008749:0.002352:0.008032:0.004998:0.003057:0.005856:0.005668:0.003257:0.003046:0.005009:0.007173:0.007644:0.003046:0.003540:0.007702:0.002352:0.007644:0.003046:0.007702:0.003692:0.003046:0.002352:0.011030:0.008032:0.007914:0.002352:0.007173:0.007914:0.003057:0.002352:0.007173:0.003057:0.008032:0.004563:0.004563:0.007644:0.004563:0.004563:0.011030:0.007644:0.007173:0.003986:0.003057:0.007702:0.003692:0.003046:0.004563:0.007644:0.006515:0.007644:0.003540:0.007644:0.003046:0.008032:0.004563:0.003986:0.007173:0.011030:0.008032:0.003257:0.003257
Curr Opin Pulm Med.:@0.101390:0.944584:0.219971:0.944584:0.219971:0.932308:0.101390:0.932308:0.009560:0.007150:0.003540:0.003540:0.003257:0.010219:0.008020:0.002352:0.007173:0.003257:0.006961:0.007150:0.002352:0.011030:0.003257:0.010807:0.007644:0.008055:0.003257
 2017;23 (1):92-109.:@0.219959:0.944584:0.327003:0.944584:0.327003:0.932308:0.219959:0.932308:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.003257:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257